Xuanzhu Biopharmaceutical Co., Ltd. Class H(HK:2575)
HK$8.89+0.54 (+6.47%)
HK:2575
Xuanzhu Biopharmaceutical Co., Ltd. Class H earnings date
HK$8.89
At close:+0.54 (+6.47%)
Want to see HK:2575 full AI Analyst Report?
Xuanzhu Biopharmaceutical Co., Ltd. Class H (2575) Q2 2026 Earnings Report
2 Followers
HK:2575 Q2 2026 EPS Results
- Actual EPS
- -HKD 0.17
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -HKD 0.23
HK:2575 Q2 2026 Revenue Results
- Actual Revenue
- HKD 79.16M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/26/2026
- Time
- Before Open
- Conference Call
- Wednesday, August 26, 2026
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
HK:2575 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Aug 26, 2026 | 2026 (Q2) | ―-0.17 | -0.23 | 27.83% (+0.06) | |
| Mar 30, 2026 | 2025 (Q4) | ―-0.28 | -0.93 | 69.56% (+0.65) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
